A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...
Nazara's revenue from operations grew 65.1 percent YoY to Rs 526.5 crore in Q2 FY26, from Rs 318.9 crore in the corresponding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback